Biophysical properties of the synucleins and their propensities to fibrillate -: Inhibition of α-synuclein assembly by β- and γ-synucleins

被引:378
作者
Uversky, VN [1 ]
Li, J
Souillac, P
Millett, IS
Doniach, S
Jakes, R
Goedert, M
Fink, AL
机构
[1] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA
[2] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia
[3] Stanford Univ, Dept Phys, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
[5] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
关键词
D O I
10.1074/jbc.M109541200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pathological hallmark of Parkinson's disease is the presence of intracellular inclusions, Lewy bodies, and Lewy neurites, in the dopaminergic neurons of the substantia nigra and several other brain regions. Fila. mentous a-synuclein is the major component of these deposits and its aggregation is believed to play an important role in Parkinson's disease and several other neurodegenerative diseases. Two homologous proteins, beta- and gamma-synucleins, are also abundant in the brain. The synucleins are natively unfolded proteins. beta-Synuclein, which lacks 11 central hydrophobic residues compared with its homologs, exhibited the properties of a random coil, whereas alpha- and gamma-synucleins were slightly more compact and structured. gamma-Synuclein, unlike its homologs, formed a soluble oligomer at relatively low concentrations, which appears to be an off-fibrillation pathway species. Here we show that, although they have similar biophysical properties to alpha-synuclein, beta- And gamma-synucleins inhibit a-synuclein fibril formation. Complete inhibition of a-synuclein fibrillation was observed at 4:1 molar excess of beta- and gamma-synucleins. No significant incorporation of beta-synuclein into the fibrils was detected. The lack of fibrils formed by beta-synuclein is most readily explained by the absence of a stretch of hydrophobic residues from the middle region of the protein. A model for the inhibition is proposed.
引用
收藏
页码:11970 / 11978
页数:9
相关论文
共 73 条
  • [1] Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4
  • [2] Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein
    Arawaka, S
    Saito, Y
    Murayama, S
    Mori, H
    [J]. NEUROLOGY, 1998, 51 (03) : 887 - 889
  • [3] Baba M, 1998, AM J PATHOL, V152, P879
  • [4] Parkinson's disease-associated α-sylnuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs
    Biere, AL
    Wood, SJ
    Wypych, J
    Steavenson, S
    Jiang, YJ
    Anafi, D
    Jacobsen, FW
    Jarosinski, MA
    Wu, GM
    Louis, JC
    Martin, F
    Narhi, LO
    Citron, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) : 34574 - 34579
  • [5] Buchman VL, 1998, J NEUROSCI, V18, P9335
  • [6] Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro
    Cohlberg, JA
    Li, J
    Uversky, VN
    Fink, AL
    [J]. BIOCHEMISTRY, 2002, 41 (05) : 1502 - 1511
  • [7] Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. BIOCHEMISTRY, 2000, 39 (10) : 2552 - 2563
  • [8] Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
    Conway, KA
    Lee, SJ
    Rochet, JC
    Ding, TT
    Williamson, RE
    Lansbury, PT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 571 - 576
  • [9] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320
  • [10] Conway KA, 2000, ANN NY ACAD SCI, V920, P42